All molnupiravir articles
-
NewsVaccinated people had lower risk of severe COVID-19 outcomes
Among people who had COVID-19, those who previously received the latest vaccine had a lower risk of having a severe outcome than those who had not, according to new research.
-
NewsWHO updates its guidance on treatments for COVID-19
The new recommendations reflect the evolving nature of the virus and the changing role of Covid-19 therapies.
-
NewsAntiviral drug linked to SARS-CoV-2 mutations
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
